ATAI · AtaiBeckley Inc.
$7.26
+0.01 (+0.14%)
At close · Aug 14
Market Cap
$2.69B
Shares
370.86M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.26
Open$7.24
Day$7.23–7.28
52W close$3.35–7.26
Avg vol 30d16.0M
Short int19.9M · 5.4% float · 1.0d
Short vol30%
Last earningsMar 6, 2026
DataJun 2021–Aug 2026
Filing10-Q · Aug 11
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 11, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+62%
above
Price vs 50-day avg
+27%
above
RSI (14)
73
overbought
MACD trend
Negative
52-week position
100%
near high
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+83%
trailing
YTD return
+78%
this year
Relative strength
+69%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+31% holders QoQ · +84 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.35% of float · ▼ -47.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
235 holders — 13F breadth
Squeeze score
52
elevated · 0–100
Fundamentals
Revenue growth
+1228%
Y/Y
EPS growth
−213%
Y/Y
Free cash flow
$-103.6M
Balance sheet
$50.1M
net debt
Quant / Vol
risk profile
Volatility
80%
annualized · 1-yr
Max drawdown
−48%
past year
ATR
2.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+62%
Bullish
Price vs 50-day avg
+27%
Bullish
RSI (14)
73
Bearish
MACD trend
Negative
Bearish
52-week position
100%
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $6 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+31% holders QoQ · +84 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.35% of float · ▼ -47.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
235 holders — 13F breadth
Price context
position in its 52-week range
Range low $3
Now $7 · 100%
Range high $7
vs 200-day avg +62%
vs 50-day avg +27%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ATAI
this stock
AtaiBeckley Inc.
|
$2.69B | +77.5% | +1227.6% | — | 5.4% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ATAI | +0.1% | +0.6% | +82.9% | +1.1% | +77.5% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -0.3% | -3.9% | +69.1% | -2.8% | +63.7% |
Key facts
CIK
2081043
CUSIP
04650F101
13F (30d)
227 filings
226 filers
Visit website
Investor relations